Artificial Organs and Bionic Implants Market By Type (Orthopedic Bionics, Ear Bionics, Others), By Technology (Electronic, Mechanical), By End User (Hospitals, Ambulatory surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
Artificial organs and bionic implants are medical devices designed to replace or enhance the functionality of natural organs or body parts. They are used to restore or improve the health and quality of life for individuals with organ failure, physical disabilities, or other medical conditions. Artificial organs are devices designed to mimic the functions of specific organs. These organs can be fully or partially artificial and are made from biocompatible materials to ensure compatibility with the body. Some examples of artificial organs include artificial hearts, artificial kidneys, artificial pancreas, and artificial limbs.
Bionic implants, on the other hand, are devices that integrate electronic or mechanical components with natural tissues to restore or enhance bodily functions. They are often used to replace or augment sensory organs, such as cochlear implants for hearing loss or retinal implants for vision impairment. Bionic limbs, also known as prosthetics, are artificial limbs that can be controlled by neural signals or muscle contractions to provide mobility and dexterity for individuals with limb loss or limb dysfunction.
Both artificial organs and bionic implants rely on advancements in technology, such as biocompatible materials, sensors, actuators, and control systems, to function effectively. These devices can significantly improve the quality of life for individuals with medical conditions, allowing them to regain lost functionality or compensate for impairments. However, it is important to note that while artificial organs and bionic implants can be highly beneficial, they may not fully replicate the natural functions of the organs they replace and may require ongoing monitoring and maintenance.
Major factors that drive the growth of the global artificial organs and bionic implants market include rapid advancements in artificial organs and bionic implants; an increase in the number of patients suffering from arthritis and blindness and a rise in the number of road accidents and injuries. For instance, according to the data by World Health Organization (WHO), in June 2022, road traffic injury was the leading cause of death among children and young adults aged 5–29 years. As per the same source, approximately 1.3 million people die each year and 20 to 50 million are injured or disabled as a result of road traffic crashes.
However, the high cost associated with implant procedures, and lack of surgical professionals are expected to restrict the growth of artificial organs and the bionic implants market. On the contrary, the surge in healthcare expenditure and unmet medical demands to get better treatment options in developing countries are expected to create lucrative opportunities for the expansion of the global market in the future.
The global artificial organs and bionic implants market is segmented on the basis of type, technology, end-user, and region. On the basis of type, the market is classified into orthopedic bionics, ear bionics, and others. The orthopedic bionics segment is further bifurcated into the bionic hand, bionic leg, and others (bionic limb, bionic finger, bone growth stimulators). Depending on technology, it is bifurcated into electronic and mechanical. By end user, it is segregated into hospitals, ambulatory surgical centers, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Abbott Laboratories, Berlin Heart GmbH, Boston Scientific Corporation, Cochlear Limited, Edward Lifesciences Corporations, Jarvik Heart, Inc., Johnson & Johnson, Medtronic plc, SynCardia Systems, LLC, and Zimmer Biomet Holding Inc. These major players have adopted product approval, agreement, acquisition, and product launch as key developmental strategies to improve the product portfolio of the artificial organs and bionic implants market.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the artificial organs and bionic implants market analysis from 2022 to 2032 to identify the prevailing artificial organs and bionic implants market opportunities.
Market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier-buyer network.
An in-depth analysis of the artificial organs and bionic implants market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes analysis of the regional as well as global artificial organs and bionic implants market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Ear Bionics
Others
Orthopedic Bionics
Orthopedic Bionics Type
Bionic Hand
Bionic Leg
Others
By Technology
Electronic
Mechanical
By End User
Hospitals
Ambulatory surgical Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Abbott Laboratories
Berlin Heart GmbH
Boston Scientific Corporation
Cochlear Limited
Edwards Lifesciences Corporation
Jarvik Heart, Inc.
Johnson & Johnson
Medtronic plc
SynCardia Systems LLC
Zimmer Biomet Holding Inc.
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report description
- 1.2. Key market segments
- 1.3. Key benefits to the stakeholders
- 1.4. Research Methodology
- 1.4.1. Primary research
- 1.4.2. Secondary research
- 1.4.3. Analyst tools and models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET OVERVIEW
- 3.1. Market definition and scope
- 3.2. Key findings
- 3.2.1. Top impacting factors
- 3.2.2. Top investment pockets
- 3.3. Porter’s five forces analysis
- 3.3.1. Bargaining power of suppliers
- 3.3.2. Bargaining power of buyers
- 3.3.3. Threat of substitutes
- 3.3.4. Threat of new entrants
- 3.3.5. Intensity of rivalry
- 3.4. Market dynamics
- 3.4.1. Drivers
- 3.4.1.1. Rise in prevalence of cardiac diseases
- 3.4.1.2. Rise in incidence of trauma and accidents
- 3.4.2. Restraints
- 3.4.2.1. High cost associated with implant procedure
- 3.4.3. Opportunities
- 3.4.3.1. Rise in adoption of key strategies
- 3.5. COVID-19 Impact Analysis on the market
- CHAPTER 4: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE
- 4.1. Overview
- 4.1.1. Market size and forecast
- 4.2. Orthopedic Bionics
- 4.2.1. Key market trends, growth factors and opportunities
- 4.2.2. Market size and forecast, by region
- 4.2.3. Market share analysis by country
- 4.2.4. Orthopedic Bionics Artificial Organs and Bionic Implants Market by Orthopedic Bionics Type
- 4.3. Ear Bionics
- 4.3.1. Key market trends, growth factors and opportunities
- 4.3.2. Market size and forecast, by region
- 4.3.3. Market share analysis by country
- 4.4. Others
- 4.4.1. Key market trends, growth factors and opportunities
- 4.4.2. Market size and forecast, by region
- 4.4.3. Market share analysis by country
- CHAPTER 5: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY
- 5.1. Overview
- 5.1.1. Market size and forecast
- 5.2. Electronic
- 5.2.1. Key market trends, growth factors and opportunities
- 5.2.2. Market size and forecast, by region
- 5.2.3. Market share analysis by country
- 5.3. Mechanical
- 5.3.1. Key market trends, growth factors and opportunities
- 5.3.2. Market size and forecast, by region
- 5.3.3. Market share analysis by country
- CHAPTER 6: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER
- 6.1. Overview
- 6.1.1. Market size and forecast
- 6.2. Hospitals
- 6.2.1. Key market trends, growth factors and opportunities
- 6.2.2. Market size and forecast, by region
- 6.2.3. Market share analysis by country
- 6.3. Ambulatory surgical Centers
- 6.3.1. Key market trends, growth factors and opportunities
- 6.3.2. Market size and forecast, by region
- 6.3.3. Market share analysis by country
- 6.4. Others
- 6.4.1. Key market trends, growth factors and opportunities
- 6.4.2. Market size and forecast, by region
- 6.4.3. Market share analysis by country
- CHAPTER 7: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY REGION
- 7.1. Overview
- 7.1.1. Market size and forecast By Region
- 7.2. North America
- 7.2.1. Key trends and opportunities
- 7.2.2. Market size and forecast, by Type
- 7.2.3. Market size and forecast, by Technology
- 7.2.4. Market size and forecast, by End User
- 7.2.5. Market size and forecast, by country
- 7.2.5.1. U.S.
- 7.2.5.1.1. Key market trends, growth factors and opportunities
- 7.2.5.1.2. Market size and forecast, by Type
- 7.2.5.1.3. Market size and forecast, by Technology
- 7.2.5.1.4. Market size and forecast, by End User
- 7.2.5.2. Canada
- 7.2.5.2.1. Key market trends, growth factors and opportunities
- 7.2.5.2.2. Market size and forecast, by Type
- 7.2.5.2.3. Market size and forecast, by Technology
- 7.2.5.2.4. Market size and forecast, by End User
- 7.2.5.3. Mexico
- 7.2.5.3.1. Key market trends, growth factors and opportunities
- 7.2.5.3.2. Market size and forecast, by Type
- 7.2.5.3.3. Market size and forecast, by Technology
- 7.2.5.3.4. Market size and forecast, by End User
- 7.3. Europe
- 7.3.1. Key trends and opportunities
- 7.3.2. Market size and forecast, by Type
- 7.3.3. Market size and forecast, by Technology
- 7.3.4. Market size and forecast, by End User
- 7.3.5. Market size and forecast, by country
- 7.3.5.1. Germany
- 7.3.5.1.1. Key market trends, growth factors and opportunities
- 7.3.5.1.2. Market size and forecast, by Type
- 7.3.5.1.3. Market size and forecast, by Technology
- 7.3.5.1.4. Market size and forecast, by End User
- 7.3.5.2. France
- 7.3.5.2.1. Key market trends, growth factors and opportunities
- 7.3.5.2.2. Market size and forecast, by Type
- 7.3.5.2.3. Market size and forecast, by Technology
- 7.3.5.2.4. Market size and forecast, by End User
- 7.3.5.3. UK
- 7.3.5.3.1. Key market trends, growth factors and opportunities
- 7.3.5.3.2. Market size and forecast, by Type
- 7.3.5.3.3. Market size and forecast, by Technology
- 7.3.5.3.4. Market size and forecast, by End User
- 7.3.5.4. Italy
- 7.3.5.4.1. Key market trends, growth factors and opportunities
- 7.3.5.4.2. Market size and forecast, by Type
- 7.3.5.4.3. Market size and forecast, by Technology
- 7.3.5.4.4. Market size and forecast, by End User
- 7.3.5.5. Spain
- 7.3.5.5.1. Key market trends, growth factors and opportunities
- 7.3.5.5.2. Market size and forecast, by Type
- 7.3.5.5.3. Market size and forecast, by Technology
- 7.3.5.5.4. Market size and forecast, by End User
- 7.3.5.6. Rest of Europe
- 7.3.5.6.1. Key market trends, growth factors and opportunities
- 7.3.5.6.2. Market size and forecast, by Type
- 7.3.5.6.3. Market size and forecast, by Technology
- 7.3.5.6.4. Market size and forecast, by End User
- 7.4. Asia-Pacific
- 7.4.1. Key trends and opportunities
- 7.4.2. Market size and forecast, by Type
- 7.4.3. Market size and forecast, by Technology
- 7.4.4. Market size and forecast, by End User
- 7.4.5. Market size and forecast, by country
- 7.4.5.1. Japan
- 7.4.5.1.1. Key market trends, growth factors and opportunities
- 7.4.5.1.2. Market size and forecast, by Type
- 7.4.5.1.3. Market size and forecast, by Technology
- 7.4.5.1.4. Market size and forecast, by End User
- 7.4.5.2. China
- 7.4.5.2.1. Key market trends, growth factors and opportunities
- 7.4.5.2.2. Market size and forecast, by Type
- 7.4.5.2.3. Market size and forecast, by Technology
- 7.4.5.2.4. Market size and forecast, by End User
- 7.4.5.3. Australia
- 7.4.5.3.1. Key market trends, growth factors and opportunities
- 7.4.5.3.2. Market size and forecast, by Type
- 7.4.5.3.3. Market size and forecast, by Technology
- 7.4.5.3.4. Market size and forecast, by End User
- 7.4.5.4. India
- 7.4.5.4.1. Key market trends, growth factors and opportunities
- 7.4.5.4.2. Market size and forecast, by Type
- 7.4.5.4.3. Market size and forecast, by Technology
- 7.4.5.4.4. Market size and forecast, by End User
- 7.4.5.5. South Korea
- 7.4.5.5.1. Key market trends, growth factors and opportunities
- 7.4.5.5.2. Market size and forecast, by Type
- 7.4.5.5.3. Market size and forecast, by Technology
- 7.4.5.5.4. Market size and forecast, by End User
- 7.4.5.6. Rest of Asia-Pacific
- 7.4.5.6.1. Key market trends, growth factors and opportunities
- 7.4.5.6.2. Market size and forecast, by Type
- 7.4.5.6.3. Market size and forecast, by Technology
- 7.4.5.6.4. Market size and forecast, by End User
- 7.5. LAMEA
- 7.5.1. Key trends and opportunities
- 7.5.2. Market size and forecast, by Type
- 7.5.3. Market size and forecast, by Technology
- 7.5.4. Market size and forecast, by End User
- 7.5.5. Market size and forecast, by country
- 7.5.5.1. Brazil
- 7.5.5.1.1. Key market trends, growth factors and opportunities
- 7.5.5.1.2. Market size and forecast, by Type
- 7.5.5.1.3. Market size and forecast, by Technology
- 7.5.5.1.4. Market size and forecast, by End User
- 7.5.5.2. Saudi Arabia
- 7.5.5.2.1. Key market trends, growth factors and opportunities
- 7.5.5.2.2. Market size and forecast, by Type
- 7.5.5.2.3. Market size and forecast, by Technology
- 7.5.5.2.4. Market size and forecast, by End User
- 7.5.5.3. South Africa
- 7.5.5.3.1. Key market trends, growth factors and opportunities
- 7.5.5.3.2. Market size and forecast, by Type
- 7.5.5.3.3. Market size and forecast, by Technology
- 7.5.5.3.4. Market size and forecast, by End User
- 7.5.5.4. Rest of LAMEA
- 7.5.5.4.1. Key market trends, growth factors and opportunities
- 7.5.5.4.2. Market size and forecast, by Type
- 7.5.5.4.3. Market size and forecast, by Technology
- 7.5.5.4.4. Market size and forecast, by End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top player positioning, 2022
- CHAPTER 9: COMPANY PROFILES
- 9.1. Berlin Heart GmbH
- 9.1.1. Company overview
- 9.1.2. Key Executives
- 9.1.3. Company snapshot
- 9.1.4. Operating business segments
- 9.1.5. Product portfolio
- 9.1.6. Key strategic moves and developments
- 9.2. Zimmer Biomet Holding Inc.
- 9.2.1. Company overview
- 9.2.2. Key Executives
- 9.2.3. Company snapshot
- 9.2.4. Operating business segments
- 9.2.5. Product portfolio
- 9.2.6. Business performance
- 9.2.7. Key strategic moves and developments
- 9.3. Boston Scientific Corporation
- 9.3.1. Company overview
- 9.3.2. Key Executives
- 9.3.3. Company snapshot
- 9.3.4. Operating business segments
- 9.3.5. Product portfolio
- 9.3.6. Business performance
- 9.4. Cochlear Limited
- 9.4.1. Company overview
- 9.4.2. Key Executives
- 9.4.3. Company snapshot
- 9.4.4. Operating business segments
- 9.4.5. Product portfolio
- 9.4.6. Business performance
- 9.4.7. Key strategic moves and developments
- 9.5. Edwards Lifesciences Corporation
- 9.5.1. Company overview
- 9.5.2. Key Executives
- 9.5.3. Company snapshot
- 9.5.4. Operating business segments
- 9.5.5. Product portfolio
- 9.5.6. Business performance
- 9.5.7. Key strategic moves and developments
- 9.6. Jarvik Heart, Inc.
- 9.6.1. Company overview
- 9.6.2. Key Executives
- 9.6.3. Company snapshot
- 9.6.4. Operating business segments
- 9.6.5. Product portfolio
- 9.7. Abbott Laboratories
- 9.7.1. Company overview
- 9.7.2. Key Executives
- 9.7.3. Company snapshot
- 9.7.4. Operating business segments
- 9.7.5. Product portfolio
- 9.7.6. Business performance
- 9.7.7. Key strategic moves and developments
- 9.8. SynCardia Systems LLC
- 9.8.1. Company overview
- 9.8.2. Key Executives
- 9.8.3. Company snapshot
- 9.8.4. Operating business segments
- 9.8.5. Product portfolio
- 9.8.6. Key strategic moves and developments
- 9.9. Medtronic plc
- 9.9.1. Company overview
- 9.9.2. Key Executives
- 9.9.3. Company snapshot
- 9.9.4. Operating business segments
- 9.9.5. Product portfolio
- 9.9.6. Business performance
- 9.10. Johnson & Johnson
- 9.10.1. Company overview
- 9.10.2. Key Executives
- 9.10.3. Company snapshot
- 9.10.4. Operating business segments
- 9.10.5. Product portfolio
- 9.10.6. Business performance
- 9.10.7. Key strategic moves and developments
- LIST OF TABLES
- TABLE 01. GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 02. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR ORTHOPEDIC BIONICS, BY REGION, 2022-2032 ($MILLION)
- TABLE 03. GLOBAL ORTHOPEDIC BIONICS ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY ORTHOPEDIC BIONICS TYPE, 2022-2032 ($MILLION)
- TABLE 04. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR EAR BIONICS, BY REGION, 2022-2032 ($MILLION)
- TABLE 05. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 06. GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 07. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR ELECTRONIC, BY REGION, 2022-2032 ($MILLION)
- TABLE 08. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR MECHANICAL, BY REGION, 2022-2032 ($MILLION)
- TABLE 09. GLOBAL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 10. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
- TABLE 11. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 12. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
- TABLE 13. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY REGION, 2022-2032 ($MILLION)
- TABLE 14. NORTH AMERICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 15. NORTH AMERICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 16. NORTH AMERICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 17. NORTH AMERICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 18. U.S. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 19. U.S. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 20. U.S. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 21. CANADA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 22. CANADA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 23. CANADA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 24. MEXICO ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 25. MEXICO ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 26. MEXICO ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 27. EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 28. EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 29. EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 30. EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 31. GERMANY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 32. GERMANY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 33. GERMANY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 34. FRANCE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 35. FRANCE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 36. FRANCE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 37. UK ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 38. UK ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 39. UK ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 40. ITALY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 41. ITALY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 42. ITALY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 43. SPAIN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 44. SPAIN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 45. SPAIN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 46. REST OF EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 47. REST OF EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 48. REST OF EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 49. ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 50. ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 51. ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 52. ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 53. JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 54. JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 55. JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 56. CHINA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 57. CHINA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 58. CHINA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 59. AUSTRALIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 60. AUSTRALIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 61. AUSTRALIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 62. INDIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 63. INDIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 64. INDIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 65. SOUTH KOREA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 66. SOUTH KOREA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 67. SOUTH KOREA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 68. REST OF ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 69. REST OF ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 70. REST OF ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 71. LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 72. LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 73. LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 74. LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
- TABLE 75. BRAZIL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 76. BRAZIL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 77. BRAZIL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 78. SAUDI ARABIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 79. SAUDI ARABIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 80. SAUDI ARABIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 81. SOUTH AFRICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 82. SOUTH AFRICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 83. SOUTH AFRICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 84. REST OF LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022-2032 ($MILLION)
- TABLE 85. REST OF LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
- TABLE 86. REST OF LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022-2032 ($MILLION)
- TABLE 87. BERLIN HEART GMBH: KEY EXECUTIVES
- TABLE 88. BERLIN HEART GMBH: COMPANY SNAPSHOT
- TABLE 89. BERLIN HEART GMBH: PRODUCT SEGMENTS
- TABLE 90. BERLIN HEART GMBH: PRODUCT PORTFOLIO
- TABLE 91. BERLIN HEART GMBH: KEY STRATERGIES
- TABLE 92. ZIMMER BIOMET HOLDING INC.: KEY EXECUTIVES
- TABLE 93. ZIMMER BIOMET HOLDING INC.: COMPANY SNAPSHOT
- TABLE 94. ZIMMER BIOMET HOLDING INC.: PRODUCT SEGMENTS
- TABLE 95. ZIMMER BIOMET HOLDING INC.: PRODUCT PORTFOLIO
- TABLE 96. ZIMMER BIOMET HOLDING INC.: KEY STRATERGIES
- TABLE 97. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
- TABLE 98. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 99. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
- TABLE 100. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 101. COCHLEAR LIMITED: KEY EXECUTIVES
- TABLE 102. COCHLEAR LIMITED: COMPANY SNAPSHOT
- TABLE 103. COCHLEAR LIMITED: PRODUCT SEGMENTS
- TABLE 104. COCHLEAR LIMITED: PRODUCT PORTFOLIO
- TABLE 105. COCHLEAR LIMITED: KEY STRATERGIES
- TABLE 106. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
- TABLE 107. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
- TABLE 108. EDWARDS LIFESCIENCES CORPORATION: PRODUCT SEGMENTS
- TABLE 109. EDWARDS LIFESCIENCES CORPORATION: SERVICE SEGMENTS
- TABLE 110. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
- TABLE 111. EDWARDS LIFESCIENCES CORPORATION: KEY STRATERGIES
- TABLE 112. JARVIK HEART, INC.: KEY EXECUTIVES
- TABLE 113. JARVIK HEART, INC.: COMPANY SNAPSHOT
- TABLE 114. JARVIK HEART, INC.: PRODUCT SEGMENTS
- TABLE 115. JARVIK HEART, INC.: PRODUCT PORTFOLIO
- TABLE 116. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 117. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 118. ABBOTT LABORATORIES: PRODUCT SEGMENTS
- TABLE 119. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 120. ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 121. SYNCARDIA SYSTEMS LLC: KEY EXECUTIVES
- TABLE 122. SYNCARDIA SYSTEMS LLC: COMPANY SNAPSHOT
- TABLE 123. SYNCARDIA SYSTEMS LLC: PRODUCT SEGMENTS
- TABLE 124. SYNCARDIA SYSTEMS LLC: PRODUCT PORTFOLIO
- TABLE 125. SYNCARDIA SYSTEMS LLC: KEY STRATERGIES
- TABLE 126. MEDTRONIC PLC: KEY EXECUTIVES
- TABLE 127. MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 128. MEDTRONIC PLC: PRODUCT SEGMENTS
- TABLE 129. MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 130. JOHNSON & JOHNSON: KEY EXECUTIVES
- TABLE 131. JOHNSON & JOHNSON: COMPANY SNAPSHOT
- TABLE 132. JOHNSON & JOHNSON: PRODUCT SEGMENTS
- TABLE 133. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
- TABLE 134. JOHNSON & JOHNSON: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 01. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032
- FIGURE 02. SEGMENTATION OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032
- FIGURE 03. TOP INVESTMENT POCKETS IN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET (2023-2032)
- FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
- FIGURE 05. LOW BARGAINING POWER OF BUYERS
- FIGURE 06. LOW THREAT OF SUBSTITUTES
- FIGURE 07. LOW THREAT OF NEW ENTRANTS
- FIGURE 08. LOW INTENSITY OF RIVALRY
- FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET
- FIGURE 10. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TYPE, 2022(%)
- FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR ORTHOPEDIC BIONICS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR EAR BIONICS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 13. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 14. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY TECHNOLOGY, 2022(%)
- FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR ELECTRONIC, BY COUNTRY 2022 AND 2032(%)
- FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR MECHANICAL, BY COUNTRY 2022 AND 2032(%)
- FIGURE 17. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, BY END USER, 2022(%)
- FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
- FIGURE 21. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET BY REGION, 2022
- FIGURE 22. U.S. ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 23. CANADA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 24. MEXICO ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 25. GERMANY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 26. FRANCE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 27. UK ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 28. ITALY ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 29. SPAIN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 30. REST OF EUROPE ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 31. JAPAN ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 32. CHINA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 33. AUSTRALIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 34. INDIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 35. SOUTH KOREA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 36. REST OF ASIA-PACIFIC ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 37. BRAZIL ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 38. SAUDI ARABIA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 39. SOUTH AFRICA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 40. REST OF LAMEA ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET, 2022-2032 ($MILLION)
- FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 45. COMPETITIVE DASHBOARD
- FIGURE 46. COMPETITIVE HEATMAP: ARTIFICIAL ORGANS AND BIONIC IMPLANTS MARKET
- FIGURE 47. TOP PLAYER POSITIONING, 2022
- FIGURE 48. ZIMMER BIOMET HOLDING INC.: NET SALES, 2020-2022 ($MILLION)
- FIGURE 49. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 50. ZIMMER BIOMET HOLDING INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 51. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
- FIGURE 52. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 53. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 54. COCHLEAR LIMITED: NET SALES, 2020-2022 ($MILLION)
- FIGURE 55. COCHLEAR LIMITED: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 56. COCHLEAR LIMITED: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 57. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2020-2022 ($MILLION)
- FIGURE 58. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 59. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
- FIGURE 60. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 61. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 62. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
- FIGURE 63. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 64. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
- FIGURE 65. JOHNSON & JOHNSON: NET SALES, 2020-2022 ($MILLION)
- FIGURE 66. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2022 (%)
- FIGURE 67. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2022 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook